Cyclacel Pharmaceuticals – Cell Cycle Inhibitor Study in Solid and Blood Cancers
Returning guest, Spiro Rombotis, President and CEO of Cyclacel Pharmaceuticals, a veteran of the industry and a developer of novel therapies that target...
270 articles
Returning guest, Spiro Rombotis, President and CEO of Cyclacel Pharmaceuticals, a veteran of the industry and a developer of novel therapies that target...
Kim Boericke, Chief Delivery Officer at THREAD, a platform for decentralized clinical trials (DCTs) discusses DCTs and some of the barriers that exist i...
Purvi Tailor, Vice President, Human Resources at Ferring Pharmaceuticals discusses the company's new family-building benefits package for all of its emp...
Laura Matrka, clinical associate professor of otolaryngology at The Ohio State University Wexner Medical Center discusses the comprehensive gender...
Joe Flanders, PhD, OPQ, Vice President, Psychology at Numinus discusses that end-of-life patients in Canada now have psilocybin-assisted therapy as a to...
Ali Tavakkoli, Chief of the Division of General and GI Surgery, co-director of the Center for Weight Management and Wellness, and director of the minima...
Medical Lead, Rare Disease at UCB discusses positive efficacy and safety results from two phase 3 studies evaluating zilucoplan, a self-administered, su...
Philip Kantoff, Co-founder and CEO of Convergent Therapeutics, a clinical-stage pharmaceutical company focused on developing next-generation radiopharma...
Scott Rombach, CEO of Specialist Direct discusses how telepathology and telehealth can make all the difference by enabling the faster evaluation of dona...
Neurosurgeon, Dr.Theresa Williamson talks about her presentation on Simplifying Surgery: Augmented Reality in Complex Spinal Procedures, which addresses...